Cargando…

Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study

BACKGROUND: The Birt-Hogg-Dubé syndrome is a rare cancer susceptibility syndrome characterised by renal tumours, lung cysts and pneumothoraces, and fibrofolliculomas. It is caused by dominantly inherited mutations in FLCN. Our objective was to report renal tumour characteristics in a large series of...

Descripción completa

Detalles Bibliográficos
Autores principales: Benusiglio, Patrick R, Giraud, Sophie, Deveaux, Sophie, Méjean, Arnaud, Correas, Jean-Michel, Joly, Dominique, Timsit, Marc-Olivier, Ferlicot, Sophie, Verkarre, Virginie, Abadie, Caroline, Chauveau, Dominique, Leroux, Dominique, Avril, Marie-Françoise, Cordier, Jean-François, Richard, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219093/
https://www.ncbi.nlm.nih.gov/pubmed/25519458
http://dx.doi.org/10.1186/s13023-014-0163-z
_version_ 1782342528915210240
author Benusiglio, Patrick R
Giraud, Sophie
Deveaux, Sophie
Méjean, Arnaud
Correas, Jean-Michel
Joly, Dominique
Timsit, Marc-Olivier
Ferlicot, Sophie
Verkarre, Virginie
Abadie, Caroline
Chauveau, Dominique
Leroux, Dominique
Avril, Marie-Françoise
Cordier, Jean-François
Richard, Stéphane
author_facet Benusiglio, Patrick R
Giraud, Sophie
Deveaux, Sophie
Méjean, Arnaud
Correas, Jean-Michel
Joly, Dominique
Timsit, Marc-Olivier
Ferlicot, Sophie
Verkarre, Virginie
Abadie, Caroline
Chauveau, Dominique
Leroux, Dominique
Avril, Marie-Françoise
Cordier, Jean-François
Richard, Stéphane
author_sort Benusiglio, Patrick R
collection PubMed
description BACKGROUND: The Birt-Hogg-Dubé syndrome is a rare cancer susceptibility syndrome characterised by renal tumours, lung cysts and pneumothoraces, and fibrofolliculomas. It is caused by dominantly inherited mutations in FLCN. Our objective was to report renal tumour characteristics in a large series of patients with the Birt-Hogg-Dubé syndrome. METHODS: We studied French Birt-Hogg-Dubé patients with a history of renal tumour. RESULTS: We included 33 patients with 21 distinct germline FLCN mutations. Median age at diagnosis of first renal tumour was 46, and age varied from 20 to 83. Twenty cases had one renal tumour, the remainder had two or more tumours. Most cases (23/33, 70%) had oncocytoma or renal cell carcinoma of the chromophobe or hybrid chromophobe-oncocytoma type, three had clear cell carcinoma (9%), and the other seven had carcinoma of papillary, undifferentiated or undetermined histology. Four cases had metastatic disease, although none died of it. CONCLUSIONS: Age at renal tumour diagnosis was highly variable, highlighting the need for regular surveillance from young adulthood to old age. Most cases had tumour types classically associated with Birt-Hogg-Dubé, i.e. oncocytoma or renal cell carcinoma of the chromophobe or hybrid type. Nevertheless, 9% had clear cell renal cell carcinoma. Geneticists, urologists and oncologists should therefore be alert to the possibility of Birt-Hogg-Dubé in patients with renal cell carcinoma of clear cell histology, especially if there are associated manifestations. Finally, the behaviour of metastatic carcinoma seemed more indolent than in sporadic renal cancers.
format Online
Article
Text
id pubmed-4219093
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42190932014-11-05 Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study Benusiglio, Patrick R Giraud, Sophie Deveaux, Sophie Méjean, Arnaud Correas, Jean-Michel Joly, Dominique Timsit, Marc-Olivier Ferlicot, Sophie Verkarre, Virginie Abadie, Caroline Chauveau, Dominique Leroux, Dominique Avril, Marie-Françoise Cordier, Jean-François Richard, Stéphane Orphanet J Rare Dis Research BACKGROUND: The Birt-Hogg-Dubé syndrome is a rare cancer susceptibility syndrome characterised by renal tumours, lung cysts and pneumothoraces, and fibrofolliculomas. It is caused by dominantly inherited mutations in FLCN. Our objective was to report renal tumour characteristics in a large series of patients with the Birt-Hogg-Dubé syndrome. METHODS: We studied French Birt-Hogg-Dubé patients with a history of renal tumour. RESULTS: We included 33 patients with 21 distinct germline FLCN mutations. Median age at diagnosis of first renal tumour was 46, and age varied from 20 to 83. Twenty cases had one renal tumour, the remainder had two or more tumours. Most cases (23/33, 70%) had oncocytoma or renal cell carcinoma of the chromophobe or hybrid chromophobe-oncocytoma type, three had clear cell carcinoma (9%), and the other seven had carcinoma of papillary, undifferentiated or undetermined histology. Four cases had metastatic disease, although none died of it. CONCLUSIONS: Age at renal tumour diagnosis was highly variable, highlighting the need for regular surveillance from young adulthood to old age. Most cases had tumour types classically associated with Birt-Hogg-Dubé, i.e. oncocytoma or renal cell carcinoma of the chromophobe or hybrid type. Nevertheless, 9% had clear cell renal cell carcinoma. Geneticists, urologists and oncologists should therefore be alert to the possibility of Birt-Hogg-Dubé in patients with renal cell carcinoma of clear cell histology, especially if there are associated manifestations. Finally, the behaviour of metastatic carcinoma seemed more indolent than in sporadic renal cancers. BioMed Central 2014-10-29 /pmc/articles/PMC4219093/ /pubmed/25519458 http://dx.doi.org/10.1186/s13023-014-0163-z Text en © Benusiglio et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Benusiglio, Patrick R
Giraud, Sophie
Deveaux, Sophie
Méjean, Arnaud
Correas, Jean-Michel
Joly, Dominique
Timsit, Marc-Olivier
Ferlicot, Sophie
Verkarre, Virginie
Abadie, Caroline
Chauveau, Dominique
Leroux, Dominique
Avril, Marie-Françoise
Cordier, Jean-François
Richard, Stéphane
Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study
title Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study
title_full Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study
title_fullStr Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study
title_full_unstemmed Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study
title_short Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study
title_sort renal cell tumour characteristics in patients with the birt-hogg-dubé cancer susceptibility syndrome: a retrospective, multicentre study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219093/
https://www.ncbi.nlm.nih.gov/pubmed/25519458
http://dx.doi.org/10.1186/s13023-014-0163-z
work_keys_str_mv AT benusigliopatrickr renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT giraudsophie renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT deveauxsophie renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT mejeanarnaud renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT correasjeanmichel renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT jolydominique renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT timsitmarcolivier renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT ferlicotsophie renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT verkarrevirginie renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT abadiecaroline renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT chauveaudominique renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT lerouxdominique renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT avrilmariefrancoise renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT cordierjeanfrancois renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT richardstephane renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy
AT renalcelltumourcharacteristicsinpatientswiththebirthoggdubecancersusceptibilitysyndromearetrospectivemulticentrestudy